Thursday, February 25, 2021

Landos Biopharma Inc. [LABP] moved up 25.81: Why It’s Important

Must read

The Goodyear Tire & Rubber Company (GT): Keeping an Eye On The Long Term

The Goodyear Tire & Rubber Company (NASDAQ: GT) has acquired rival Cooper Tire & Rubber Company (NYSE: CTB) for $2.8 billion. The takeover will...

OCUL stock: Ocular Therapeutix (OCUL) Is Better Than You Think

Ocular Therapeutix (OCUL) has performed well over the past year. OCUL has experienced a 248.76% gain in the last year, while its stock has...

Landos Biopharma Inc. [NASDAQ: LABP] jumped around 2.87 points on Tuesday, while shares priced at $13.99 at the close of the session, up 25.81%. The company report on February 4, 2021 that Landos Biopharma Announces Pricing of Initial Public Offering.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Landos Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, announced the pricing of its initial public offering of 6,250,000 shares of common stock at the public offering price of $16.00 per share, for total gross proceeds of $100 million, before deducting underwriting discounts and commissions and offering expenses payable by Landos Biopharma. All of the shares of the common stock are being offered by Landos Biopharma.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


The shares are expected to begin trading on the Nasdaq Global Select Market on February 4, 2021 under the trading symbol of “LABP.” The offering is expected to close on February 8, 2021, subject to customary closing conditions. In addition, Landos Biopharma has granted the underwriters a 30-day option to purchase up to an additional 937,500 shares of its common stock at the initial public offering price less the underwriting discounts and commissions.

Compared to the average trading volume of 1.66M shares, LABP reached a trading volume of 1793188 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Landos Biopharma Inc. [LABP]?

The Average True Range (ATR) for Landos Biopharma Inc. is set at 2.76

How has LABP stock performed recently?

Landos Biopharma Inc. [LABP]: Deeper insight into the fundamentals

Return on Total Capital for LABP is now -54.86, given the latest momentum, and Return on Invested Capital for the company is -55.59. Return on Equity for this stock declined to -55.59, with Return on Assets sitting at -50.56.

Landos Biopharma Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.50 and a Current Ratio set at 4.50.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

The Goodyear Tire & Rubber Company (GT): Keeping an Eye On The Long Term

The Goodyear Tire & Rubber Company (NASDAQ: GT) has acquired rival Cooper Tire & Rubber Company (NYSE: CTB) for $2.8 billion. The takeover will...

OCUL stock: Ocular Therapeutix (OCUL) Is Better Than You Think

Ocular Therapeutix (OCUL) has performed well over the past year. OCUL has experienced a 248.76% gain in the last year, while its stock has...

Examining the Technicals of Levi Strauss & Co (NYSE: LEVI)

Levi Strauss & Co (NYSE: LEVI), one of the world's most famous denim brands, is recovering from the COVID-19 crisis. As a result of...

Philip Morris International’s Stock Is Driven By IQOS’s Increasing Growth: PM Stock

Shares of Philip Morris International (PM) reacted positively to the fourth quarter's earnings report. PM-related firms' stocks rose 8.77% for the week, with a...

AMC and GameStop Stocks Are No Longer Restricted In Robinhood

Robinhood Markets' decision to lift trading restrictions on GameStop and AMC Entertainment shares has resulted in their recovery before the conference. The two companies...

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.